In Brief: America's Best Nutrition warning letter
This article was originally published in The Tan Sheet
Executive Summary
America's Best Nutrition warning letter: Trim-Phen name and label statements that the dietary supplement is an "all natural `alternative'" to the prescription obesity drug phentermine render the product an unapproved new drug, FDA tells the Destin, Fla.-based company Dec. 24. The agency also cites the "lack of any evidence that these products are generally recognized as safe and effective for the treatment of obesity." FDA issued a "Talk Paper" in November declaring "herbal phen-fen" products to be unapproved new drugs ("The Tan Sheet" Nov. 10, 1997, p. 3)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning